New CKM guideline urges team-based care, yet UH data show major therapy gaps; CINEMA model boosts outcomes amid cost, trust, and handoff hurdles.
|Articles|May 1, 1996
Supplements and Featured Publications
- Shifting Paradigms in the Treatment of Acid-Related Disorders
- Volume 2
- Issue 7 Suppl
Interview
Author(s)James W. Freston, MD, PhD
Advertisement
Articles in this issue
over 30 years ago
Reflux Esophagitis/GERDover 30 years ago
Duodenal/Gastric Ulcerover 30 years ago
Analysis: PPIs and H2RAsover 30 years ago
Selected Abstractsover 30 years ago
CME Quizover 30 years ago
Gastroesophageal Diseaseover 30 years ago
Introductionover 30 years ago
Goals and Objectivesover 30 years ago
Participating FacultyAdvertisement
Related to this article
Obesity care surges with GLP-1 demand, but fragmented ownership, prior authorizations, and coverage rules stall treatment—pharmacists step in.
Roundtables reveal HFpEF/HFmrEF care lags despite rising cases; learn new SGLT2/MRA strategies, screening, and scalable team pathways.
Simple operational changes are proving more effective at closing gaps in cardiovascular-kidney-metabolic (CKM) syndrome care than education campaigns alone, according to panelists at at Population Health Roundtable
Panelists at AJMC roundtables in Philadelphia, Boston, Washington, DC, and Chicago traced why atopic dermatitis stays undertreated despite new therapies.
Eye care access for underserved patients with diabetes is limited and poorly understood. We identified barriers and innovative solutions to improve overall care and establish evidence-based practices.
Patient understanding should be treated as a measurable equity outcome, not an assumed byproduct of care.
Advertisement
Advertisement
Trending on AJMC
1
Delayed Dupilumab Raises Asthma Costs 32%: Nicola Hanania, MD
2
Regorafenib Prescribing in Advanced GIST Deviates From Guidelines
3
Which Antibiotics Raise C. Diff Risk Most? Jason Pogue, PharmD
4
A Patient-Centered Reconstruction of 340B in Oncology: Transparency, Equity, and Site-of-Care Accountability
5